Antibody subclasses as a tool for Helicobacter pylori antigen characterization  by Martinez, F. et al.
trac
i
a
u
i
q
ﬁ
a
3
3
b
l
c
l
f
a
d
5
A
3
A
M
1
o
2
3
e
p
c
c
d
a
c
i
p
e
l
(
f
n
w
a
(
p
o
r
0
f
f14th International Congress on Infectious Diseases (ICID) Abs
52.024
Antibody subclasses as a tool for Helicobacter pylori anti-
gen characterization
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Background: Helicobacter pylori is a bacteria that colo-
nizes about 50% of the world population. H. pylori infection
is associated with severe disease including peptic ulcer
and gastric cancer. Several factors have been proposed as
important for this variability. Among the factors that pos-
sibly participate in this variable disease outcome is the
host’s immune response. Antibody subclass markers could be
important markers for disease outcome and could be used
as interesting markers of the development and polarization
of immune response. Therefore, we characterized the dif-
ferences in subclass antigenic recognition according to H.
pylori associated disease and source of antigen.
Methods: IgG1 and IgG2 titres were determined by ELISA
in 44 sera of patients with different H. pylori associated dis-
eases (Gastric cancer, peptic ulcer and dyspepsia). H. pylori
antigens were obtained from 12 different clinical isolates
from similar associated diseases.
Results: When the IgG1 and IgG2 titres were analyzed, we
found higher IgG2 titres across all titre determinations unre-
strictive of pathology. In particular, peptic ulcer patients
showed higher IgG2 /gG1 titre ratios. Source of antigen also
had an effect on these determinations, as dyspepsia derived
antigens revealed higher IgG1 titres across all screened sera.
Conclusion: There was an increase in IgG2 titres in all
sera, in concordance with a Th1 response. This increase is
more represented in peptic ulcer patients. Antigen source
was found to be a variable in these determinations, which
represents a novel characteristic of subclass-associated
antigenic analysis.
doi:10.1016/j.ijid.2010.02.1982
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Age-speciﬁc seroprevalence of hepatitis A in SARI (north-
ern part of IRAN)
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Background: Hepatitis A virus (HAV) is an enteric, viral,
infectious disease still endemic in many developing coun-
tries such as Iran. Improved sanitary condition has generally
resulted in a signiﬁcant decline in the incidence of hepatitis
A. However, a low incidence of infection results in increased
HAV susceptibility. The present study investigates the sero-
prevalence of hepatitis A virus antibodies in relation to age
to clarify the current HAV status and HAV susceptibility in
the city of Sari, northern part of Iran.
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Methods: A total of 1034 Serum samples collected dur-
ng 2007 from Iranian urban and rural individuals ranging in
ge from 1- 25 years, were tested for anti-HAV IgG antibody
sing a commercial enzyme immunoassay kit. Subjects were
nvestigated using a standardized social and medical history
uestionnaire. In data analysis, we use X2 (chi-square) and
sher exact test.
Results: 1034 subjects were enrolled including 620 urban
nd 414 rural people. The overall seroprevalence rate was
8.8%. There were 192 children under 5 years old and
30 subjects between 5 and 15 years and 512 subjects
etween 15 to 25 years old.. There was signiﬁcant corre-
ation between ages, parent’s educational levels and home
ondition with anti HAV antibody levels.
Conclusion: The surveillance of anti-HAV antibody preva-
ence is useful for implementing preventive measures and
or controlling the spread of HAV. It seems that immunization
gainst HAV will be needed in early future in our Population.
oi:10.1016/j.ijid.2010.02.1983
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Background: Hepatitis B virus (HBV) infection is a major
ublic health problem worldwide. The mechanism of sus-
eptibility to chronic persistent HBV infection is not well
lariﬁed, while the outcome of HBV infection mainly
epends on the host immune response. Different HLA class 1
nd 2 alleles may play roles in HBV infection outcome. The
urrent study aimed to determine association between HBV
nfection outcome and HLA-A and DRB1 genotyping in North
art of Iran.
Methods: Ninety-four HBV infected patients were
nrolled in this study. First HLA-A and DRB1 alleles were ana-
yzed by using low resolution PCR sequence-speciﬁc-primer
PCRSSP) and then we used high resolution PCR-SSP method
or subtyping HLA-A*33 and DRB1*13 alleles which were sig-
iﬁcantly related to the outcome of HBV infection.
Results: The frequency of A*33 allele in persistent group
as higher than in recovered group (9.37% vs. 0%, P < 0.008)
nd sub typing showed HLA-A*3303 and HLA-A*3301 in 75%
allele frequency: 7.3) and 25% (allele frequency: 2.34) of
ersistent HBV infected cases respectively. The frequency
f DRB1*13 allele was lower in persistent group than in
ecovered group (3.13% vs. 11.67%, P < 0.03, OR = 0.22, 95%CI
.06-0.82), and HLADRB1* 1301 and HLA-DRB1*1303 were
ound in 66.7%(allele frequency: 4.89) and 33.3% (allele
requency: 3.45) of cases respectively. HLA-A*3303 and
RB1*1301 were the predominant subtypes of HLA-A*33 and
RB1*13 at high resolution PCR-SSP method.
Conclusion: Host HLA polymorphism is an important
actor to determining the outcome of HBV infection. HLA-
